Molecular Devices, with the help of Terminus and Khronos, implemented a strategic ABM approach to enhance engagement and revenue within the life sciences sector. Targeting key accounts across diverse use cases, the ABM campaigns focused on demand generation for mature products, support for new product launches, and outreach to smaller accounts with regulatory requirements. Over eight months, the program engaged 90% of the target account list, surpassing pipeline and revenue goals. This success led to expanded ABM adoption and recognition for leadership, demonstrating ABM’s effectiveness in scaling targeted, multi-channel engagement and optimizing account-focused outreach in complex market segments.

Join for free to read